High-dose intravenous corticosteroids used to treat acute optic neuritis, giant cell arteritis, and other inflammatory conditions.
Intravenous (IV) steroid treatment delivers high doses of corticosteroids directly into the bloodstream. It's used for acute inflammatory conditions affecting the optic nerve and visual system.
Key Takeaways
- High-dose steroids given through IV line
- Speeds recovery in optic neuritis
- Critical for giant cell arteritis
- Usually 3-5 days of infusions
- Often followed by oral steroids
Common Uses
- Acute optic neuritis
- Giant cell arteritis (initially)
- NMO attacks
- MOGAD attacks
- Severe thyroid eye disease
- Other inflammatory optic neuropathies
What to Expect
Before Treatment
- Blood tests (glucose, electrolytes)
- Blood pressure check
- Review of current medications
- May need IV line placed
During Treatment
- IV infusion over 1-2 hours
- Usually methylprednisolone 1 gram daily
- Typically 3-5 consecutive days
- Can be done outpatient in infusion center
Side Effects During Infusion
- Metallic taste
- Flushing
- Mild restlessness
- Sleep disturbance
- Elevated blood sugar
After Treatment
Short-Term Effects
- Mood changes (up or down)
- Insomnia
- Increased appetite
- Elevated blood pressure
- High blood sugar
Oral Steroid Taper
- Often prescribed after IV course
- Gradual dose reduction over weeks
- Prevents rebound inflammation
For Optic Neuritis
Based on the ONTT (Optic Neuritis Treatment Trial):
- Speeds recovery but doesn't change final vision
- May reduce risk of MS in short term
- Standard approach for moderate-severe cases
For Giant Cell Arteritis
- Often life-saving and vision-saving
- Started immediately when suspected
- Followed by oral steroids for months
- Don't wait for biopsy results
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice.
Medically Reviewed Content
This article meets our editorial standards
- Written by:
- Hashemi Eye Care Medical Team
- Medically reviewed by:
- Board-Certified Neuro-Ophthalmologist (MD, Neuro-Ophthalmology)
- Last reviewed:
- January 30, 2025
